Advanced PET scans reveal that late-life depression and bipolar disorder may signal early neurodegenerative changes before dementia symptoms emerge.
Key Details
- 1Study involved 52 late-life mood disorder (LLMD) patients and 47 controls using PET imaging for tau and amyloid proteins.
- 2~50% of LLMD patients showed abnormal tau accumulation vs. 15% of controls; 29% had amyloid vs. 2% of controls.
- 3Autopsy of 208 brain cases confirmed higher tau-related pathologies in those with late-life mood symptoms.
- 4Pathological protein buildup detectable an average of 7.3 years before cognitive or motor symptoms.
- 5Study used two PET tracers to capture diverse tau and amyloid pathologies.
- 6Findings support tau-PET as a tool for early detection of neurodegenerative diseases in psychiatric populations.
Why It Matters
These findings advance the role of molecular PET imaging in diagnosing neurodegenerative diseases at the preclinical stage—especially in patients with mood disorders—enabling earlier interventions and reshaping the clinical approach to late-onset psychiatric presentations.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.